The influence of simultaneous integrated boost, hypofractionation and oncoplastic surgery on cosmetic outcome and PROMs after breast conserving therapy

J.T.P. Lansu, M. Essers, A.C. Voogd, E.J.T. Luiten, C. Buijs, N. Groenendaal, P.M.H. Poortmans

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Introduction: We retrospectively investigated the possible influence of a simultaneous integrated boost (SIB), hypofractionation and oncoplastic surgery on cosmetic outcome in 125 patients with stage I-II breast cancer treated with breast conserving therapy (BCT).

Patients and methods: The boost was given sequentially (55%) or by SIB (45%); fractionation was conventional (83%) or hypofractionated (17%); the surgical technique was a conventional lumpectomy (74%) or an oncoplastic technique (26%). We compared cosmetic results subjectively using a questionnaire independently completed by the patient and by the physician and objectively with the BCCT.core software. Independent-samples.T-tests were used to compare outcome in different groups. Patients also completed the EORTC QLQ C30 and BR23.

Results: Univariate analyses indicated no significant differences of the cosmetic results (P

Conclusion: Our study indicates that the current RT techniques seem to be safe for cosmetic outcome and quality of life. Further investigation is needed to verify the possible negative influence of oncoplastic surgery on the cosmetic outcome and the quality of life as this technique is especially indicated for patients with an unfavourable tumour/breast volume ratio. (C) 2015 Elsevier Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)1411-1416
Number of pages6
JournalEuropean Journal of Surgical Oncology
Volume41
Issue number10
DOIs
Publication statusPublished - Oct 2015

Keywords

  • Simultaneous integrated boost (SIB)
  • Hypofractionation
  • Oncoplastic surgery
  • Cosmetic results
  • Quality of life (QOL)
  • Breast conserving therapy
  • QUALITY-OF-LIFE
  • EUROPEAN-ORGANIZATION
  • RANDOMIZED-TRIAL
  • EORTC BOOST
  • YOUNG-WOMEN
  • CANCER
  • RADIATION
  • IRRADIATION
  • MASTECTOMY
  • TUMOR

Cite this